Human mesenchymal stem cell culture: Rapid and efficient isolation and expansion in a defined serum-free medium

Journal of Tissue Engineering and Regenerative Medicine

Volumn 6, Issue 5, 2012, Pages 391-403

  Jung, Sunghoon ^a   Sen, Arindom ^a   Rosenberg, Lawrence ^b   Behie, Leo A ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Clonal growth; Defined medium; Expansion; Growth kinetics; Isolation; Mesenchymal stem cells; Morphology; Primary culture

Indexed keywords

BODY FLUIDS; BONE; CELL GROWTH; POPULATION STATISTICS; STEM CELLS; TISSUE CULTURE;

CELL/B.E; CLONAL GROWTH; DEFINED MEDIUMS; DEFINED SERUM-FREE MEDIUM; FETAL BOVINE SERUM; HUMAN MESENCHYMAL STEM CELLS; ISOLATION; MESENCHYMAL STEM CELL; PRIMARY CULTURE; STEM CELL CULTURE;

GROWTH KINETICS;

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; BETA1 INTEGRIN; CD14 ANTIGEN; CD19 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; HERMES ANTIGEN; HLA ANTIGEN; HLA DR ANTIGEN; MICROSOMAL AMINOPEPTIDASE; THY 1 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL ADHESION; CELL AGGREGATION; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; STEM CELL EXPANSION;

EID: 84859955767     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.441     Document Type: Article

References (41)

1. Apel A, Groth A, Schlesinger S, et al. 2009; Suitability of human mesenchymal stem cells for gene therapy depends on the expansion medium. Exp Cell Res 315: 498-507.
2. Bieback K, Hecker A, Kocaömer A, et al. 2009; Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 27: 2331-2341.
3. Bruder SP, Jaiswal N, Haynesworth SE. 1997; Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64: 278-294.
4. Capelli C, Domenghini M, Borleri G, et al. 2007; Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts. Bone Marrow Transpl 40: 785-791.
5. Castro-Malaspina H, Gay RE, Resnick G, et al. 1980; Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 56: 289-301.
6. Chase LG, Lakshmipathy U, Solchaga LA, et al. 2010; A novel serum-free medium for the expansion of human mesenchymal stem cells. Stem Cell Res Ther 2: 1-8.
7. Colter DC, Class R, DiGirolamo CM, et al. 2000; Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA 97: 3213-3218.
8. Colter DC, Sekiya I, Prockop DJ. 2001; Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci USA 98: 7841-7845.
9. Cristofalo VJ, Allen RG, Pignolo RJ, et al. 1998; Relationship between donor age and the replicative lifespan of human cells in culture: a re-evaluation. Proc Natl Acad Sci USA 95: 10614-10619.
10. Digirolamo CM, Stokes D, Colter D, et al. 1999; Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 107: 275-281.
11. Dimarakis I, Levicar N. 2006; Cell culture medium composition and translational adult bone marrow-derived stem cell research. Stem Cells 24: 1407-1408.
12. Dominici M, Le Blanc K, Mueller I, et al. 2006; Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
13. Doucet C, Ernou I, Zhang Y, et al. 2005; Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 205: 228-236.
14. Frauenschuh S, Reichmann E, Ibold Y, et al. 2007; A microcarrier-based cultivation system for expansion of primary mesenchymal stem cells. Biotechnol Prog 23: 187-193.
15. Higuera G, Schop D, Janssen F, et al. 2009; Quantifying in vitro growth and metabolism kinetics of human mesenchymal stem cells using a mathematical model. Tissue Eng 15: 2653-2663.
16. Javazon EH, Beggs KJ, Flake AW. 2004; Mesenchymal stem cells: paradoxes of passaging. Exp Hematol 32: 414-425.
17. Jung S, Sen A, Rosenberg L, et al. 2010; Identification of growth and attachment factors for the serum-free isolation and expansion of human mesenchymal stromal cells. Cytotherapy 12: 637-657.
18. Kocaoemer A, Kern S, Klüter H, et al. 2007; Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 25: 1270-1278.
19. Kuo CK, Tuan RS. 2003; Tissue engineering with mesenchymal stem cells. IEEE Eng Med Biol Mag 22: 51-56.
20. Kuznetsov SA, Friedenstein AJ, Robey PG. 1997; Factors required for bone marrow stromal fibroblast colony formation in vitro. Br J Haematol 97: 561-570.
21. Lange C, Cakiroglu F, Spiess AN, et al. 2007; Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol 213: 18-26.
22. Larson BL, Ylöstalo J, Prockop DJ. 2008; Human multipotent stromal cells undergo sharp transition from division to development in culture. Stem Cells 26: 193-201.
23. Le Blanc K, Samuelsson H, Lönnies L, et al. 2007; Generation of immunosuppressive mesenchymal stem cells in allogeneic human serum. Transplantation 84: 1055-1059.
24. Lennon DP, Haynesworth SE, Young RG, et al. 1995; A chemically defined medium supports in vitro proliferation and maintains the osteochondral potential of rat marrow-derived mesenchymal stem cells. Exp Cell Res 219: 211-222.
25. Liu CH, Wu ML, Hwang SM. 2007; Optimization of serum-free medium for cord blood mesenchymal stem cells. Biochem Eng J 33: 1-9.
26. Mannello F, Tonti GA. 2007; Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free, medium with fetal calf serum, human serum, or enriched plasma, serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold! Stem Cells 25: 1603-1609.
27. Marshak DR, Holecek JJ. 1999; Chemical defined medium for human mesenchymal stem cells. US Patent No. 5908782.
28. Müller I, Kordowich S, Holzwarth C, et al. 2006; Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy 8: 437-444.
29. Ozturk SS, Palsson BO. 1991; Growth, metabolic, and antibody production kinetics of hybridoma cell culture: 1. Analysis of data from controlled batch reactors. Biotechnol Prog 7: 471-480.
30. Pittenger MF, Mackay AM, Beck SC, et al. 1999; Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
31. Prockop DJ, Brenner M, Fibbe WE, et al. 2010; Defining the risks of mesenchymal stromal cell therapy. Cytotherapy 12: 576-578.
32. Reinisch A, Bartmann C, Rohde E, et al. 2007; Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application. Regen Med 2: 371-382.
33. Schallmoser K, Bartmann C, Rohde E, et al. 2007; Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47: 1436-1446.
34. Schop D, Janssen FW, Borgart E, et al. 2008; Expansion of mesenchymal stem cells using a microcarrier-based cultivation system: growth and metabolism. J Tissue Eng Regen Med 2: 126-135.
35. Schop D, Janssen FW, van Rijn LD, et al. 2009; Growth, metabolism, and growth inhibitors of mesenchymal stem cells. Tissue Eng 15: 1877-1886.
36. Schop D, van Dijkhuizen-Radersma R, Borgart E, et al. 2010; Expansion of human mesenchymal stromal cells on microcarriers: growth and metabolism. J Tissue Eng Regen Med 4: 131-140.
37. Sekiya I, Larson BL, Smith JR, et al. 2002; Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 20: 530-541.
38. Stute N, Holtz K, Bubenheim M, et al. 2004; Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol 32: 1212-1225.
39. Tateishi K, Ando W, Higuchi C, et al. 2008; Comparison of human serum with fetal bovine serum for expansion and differentiation of human synovial MSC: potential feasibility for clinical applications. Cell Transpl 17: 549-557.
40. Wan C, He Q, McCaigue M, et al. 2006; Nonadherent cell population of human marrow culture is a complementary source of mesenchymal stem cells (MSCs). J Orthop Res 24: 21-28.
41. Ylöstalo J, Bazhanov N, Prockop DJ. 2008; Reversible commitment to differentiation by human multipotent stromal cells in single-cell-derived colonies. Exp Hematol 36: 1390-1402.